Endothelin A receptor antagonists in diabetic kidney disease

Current Opinion in Nephrology and Hypertension
Panagiotis I Georgianos, Rajiv Agarwal

Abstract

Despite optimal therapy of diabetic nephropathy with agents blocking the renin-angiotensin-aldosterone system, the residual risk of nephropathy progression to end-stage renal disease (ESRD) remains high. The purpose of this review is to discuss the potential role of endothelin antagonism as a therapeutic tool to reduce residual proteinuria and delay kidney injury progression among patients with diabetic nephropathy. Preclinical studies have shown that endothelin receptor antagonists (ERAs) exert proteinuria lowering and nephroprotective actions in experimental models of diabetic nephropathy. ERAs reduce proteinuria in phase 2 trials that included therapy with renin-angiotensin-aldosterone system blockers. Safety of these agents and protection from ESRD needs to be demonstrated in phase 3 trials. Excess risk of fluid retention and heart failure risk remains. The hypothesis that the antiproteinuric effect of endothelin antagonism may be translated into a slower progression of diabetic nephropathy to ESRD is investigated in ongoing randomized trials assessing 'hard' renal endpoints. ERAs may represent a promising tool toward renoprotection in diabetic nephropathy by individualizing therapy and mitigating the risk of heart failure,...Continue Reading

References

Aug 1, 1990·Journal of Molecular and Cellular Cardiology·H KawaguchiH Yasuda
Sep 22, 2001·The New England Journal of Medicine·E J LewisUNKNOWN Collaborative Study Group
Sep 22, 2001·The New England Journal of Medicine·B M BrennerUNKNOWN RENAAL Study Investigators
Sep 19, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Marie-Luise GrossKerstin Amann
Feb 3, 2005·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Robert C AtkinsEdmund J Lewis
Apr 20, 2005·Journal of Cardiovascular Pharmacology·Koh-ichi SugimotoAkio Fujimura
Dec 7, 2006·The American Journal of Pathology·Marina MorigiCarla Zoja
Dec 15, 2006·Journal of the American Society of Nephrology : JASN·Jennifer M SasserJennifer S Pollock
Jun 9, 2007·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Neeraj DhaunDavid J Webb
Jan 16, 2009·Journal of the American Society of Nephrology : JASN·René R WenzelUNKNOWN SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators
Aug 14, 2009·American Journal of Physiology. Renal Physiology·Elena GagliardiniAriela Benigni
Feb 20, 2010·Journal of the American Society of Nephrology : JASN·Johannes F E MannUNKNOWN ASCEND Study Group
Mar 5, 2011·Journal of the American Society of Nephrology : JASN·Donald E KohanDennis L Andress
Apr 8, 2011·The Journal of Pharmacology and Experimental Therapeutics·Mohamed A SalehDavid M Pollock
Jan 21, 2012·The Review of Diabetic Studies : RDS·Hiddo J Lambers Heerspink, Dick de Zeeuw
May 24, 2013·American Journal of Physiology. Renal Physiology·I Jeanette LynchCharles S Wingo
May 28, 2013·The Journal of Pharmacology and Experimental Therapeutics·Deborah StuartDonald E Kohan
Jan 11, 2014·Clinical Journal of the American Society of Nephrology : CJASN·Jamo HoekmanDick de Zeeuw
Apr 12, 2014·Journal of the American Society of Nephrology : JASN·Dick de ZeeuwHans-Henrik Parving
May 9, 2014·Kidney International·Donald E Kohan, Matthias Barton
Nov 26, 2014·Journal of the American Society of Nephrology : JASN·Hiddo J Lambers HeerspinkUNKNOWN Reducing Albuminuria as Surrogate Endpoint (REASSURE) Consortium
May 13, 2015·Seminars in Nephrology·Donald E Kohan
Jul 15, 2015·Clinical Journal of the American Society of Nephrology : CJASN·Donald E KohanDick de Zeeuw
Aug 1, 2015·European Journal of Preventive Cardiology·Bauke SchievinkHiddo J Lambers Heerspink

❮ Previous
Next ❯

Citations

Jul 6, 2019·Journal of Diabetes and Metabolic Disorders·Arjun JainAshok Jain
Apr 23, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Sebastiano IntagliataGiuseppe Romeo
May 18, 2021·BioMed Research International·LinLin ChenHu Wang
Jul 31, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Junmin WangGuang Ji
Aug 8, 2021·International Journal of Molecular Sciences·Li WangHui-Yao Lan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Alicja CzopekNeeraj Dhaun
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Radko Komers, Horacio Plotkin
Contributions to Nephrology
Kerstin Benz, Kerstin Amann
Clinical Journal of the American Society of Nephrology : CJASN
George L Bakris
© 2022 Meta ULC. All rights reserved